Keytruda works by inhibiting the activity of the programmed cell death protein 1 (PD-1), which typically limits the activity of your immune system. Cancer cells often produce PD-1 to prevent your ...
RAHWAY, N.J.--(BUSINESS WIRE)-- Merck (MRK), known as MSD outside the United States and Canada, today announced positive topline results from the Phase 3 KEYNOTE-B15 trial (also known as EV-304) in ...
First pivotal Phase 3 trial to show superiority of KEYTRUDA plus a TROP2 antibody-drug conjugate, Trodelvy, versus standard of care in first-line metastatic TNBC “These results have the potential to ...
Overview: Keytruda Qlex is a medicine that is used to treat many types of cancer. This medicine is given to you as an injection under your skin by a health care provider. This medicine can cause side ...
Euronews on MSN
Un vaccin prometteur contre le mélanome agressif pourrait mobiliser les défenses antitumorales
Un vaccin à ARNm personnalisé, mis au point par Moderna et Merck, apporte des bénéfices durables aux patients atteints d’un ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback